127
Participants
Start Date
July 1, 2020
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
Selinexor
Participants will receive Selinexor oral tablets.
Dexamethasone
Participants will receive Dexamethasone oral tablets.
Bortezomib
Participants will receive Bortezomib SC injection.
COMPLETED
University General Hospital of Patras, Pátrai
RECRUITING
Bnai-Zion Medical Center, Haifa
RECRUITING
"General Hospital of Athens Evaggelismos", Athens
RECRUITING
"General Hospital of Athens ALEXANDRA", Attiki
RECRUITING
Rabin Medical Center (Beilinson Hospital), Petah Tikva
RECRUITING
The Chaim Sheba Medical Center at Tel HaShomer, Ramat Gan
RECRUITING
Theageneion Cancer Hospital, Thessaloniki
RECRUITING
Tel Aviv Sourasky Medical Center, Tel Aviv
RECRUITING
Emek Medical Center, Afula
RECRUITING
Rambam Health Care Campus, Haifa
COMPLETED
Meir Medical Center, Kfar Saba
RECRUITING
Assuta Ashdod Medical Center, Ashdod
RECRUITING
Barzilai Medical Center, Ashkelon
RECRUITING
Shaare Zedek Medical Center, Jerusalem
RECRUITING
Hadassah Medical Center, Jerusalem
RECRUITING
"General Hospital of Athens Alexandra", Athens
ACTIVE_NOT_RECRUITING
Soroka University Medical Center, Beersheba
Lead Sponsor
Karyopharm Therapeutics Inc
INDUSTRY